Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 4834

#IAS25: Merck sends new monthly oral PrEP to Phase 3 after earlier islatravir setback

$
0
0
KIGALI, RWANDA — Three years after a safety disappointment halted earlier plans for a once-monthly HIV PrEP candidate, Merck is back in the late stages of development with a next-generation effort. The New Jersey company said ...

Viewing all articles
Browse latest Browse all 4834

Trending Articles